Livres sur le sujet « Bone resorption »

Pour voir les autres types de publications sur ce sujet consultez le lien suivant : Bone resorption.

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les 50 meilleurs livres pour votre recherche sur le sujet « Bone resorption ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Parcourez les livres sur diverses disciplines et organisez correctement votre bibliographie.

1

Felix, Bronner, Farach-Carson Mary C. 1958- et Rubin Janet, dir. Bone resorption. London : Springer, 2005.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
2

Bronner, Felix, Mary C. Farach-Carson et Janet Rubin, dir. Bone Resorption. London : Springer-Verlag, 2005. http://dx.doi.org/10.1007/b136184.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
3

Harvey, Wilson. Prostaglandins in bone resorption. Boca Raton, Fla : CRC Press, 1988.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
4

Pierce, Angela Mary. Cellular mechanisms in bone and tooth resorption : Morphological studies in rats and monkeys. Stockholm : Kongl. Carolinska Medico Chirurgiska Institutet, 1988.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
5

Brown, R. James. Histological and compositional responses of bone to immobilization and other experimental conditions : Semi-annual report. San Francisco, Calif : Institute of Chemical Biology, University of San Francisco, 1985.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
6

Arun, Shanbhag, Rubash Harry E et Jacobs Joshua J. 1956-, dir. Joint replacement and bone resorption : Pathology, biomaterials, and clinical practice. New York : Taylor & Francis, 2005.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
7

Maria, Bijvoet Olav Leonardus, dir. Bisphosphonate on bones. Amsterdam : Elsevier, 1995.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
8

Åkesson, Louise. Panoramic radiography in the assessment of the marginal bone level. Malmö : Department of Oral Radiology, Faculty of Odontology, Lund University, 1991.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
9

Fleisch, Herbert. Bisphosphonates in bone disease : From the laboratory to the patient. Bern : H. Fleish, 1993.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
10

Jonasson, Grethe. Mandibular alveolar bone mass, structure and thickness in relation to skeletal bone density in dentate women. Göteborg : Department of Orthodontics, Faculty of Odontology, The Sahlgrenska Academy at Göteborg University, 2005.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
11

Loomer, Peter Michael. The direct effects of Porphyromonas Gingivalis 2561 on bone formation and mineral resorption in vitro. [Toronto : University of Toronto, Faculty of Dentistry], 1997.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
12

Fleisch, Herbert. Bisphosphonates in bone disease : From the laboratory to the patient. 3e éd. New York : Parthenon Pub. Group, 1997.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
13

Fleisch, Herbert. Bisphosphonates in bone disease : From the laboratory to the patient. 2e éd. New York : Parthenon Pub. Group, 1995.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
14

Fleisch, Herbert. Bisphosphonates in bone disease : From the laboratory to the patient. 4e éd. San Diego : Academic Press, 2000.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
15

D, Rubens R., et European Conference on Clinical Oncology (5th : 1989 : London, England), dir. The Management of bone metastases and hypercalcaemia by osteoclast inhibition : An international symposium held during the 5th European Conference on Clinical Oncology (ECCO 5), London, September 1989. Toronto : Hogrefe & Huber, 1990.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
16

Congress, European Society for Medical Oncology. Disodium pamidronate (APD) in the treatment of malignancy-related disorders : An international symposium held during the 13th Congress of the European Society for Medical Oncology (ESMO), Lugano, Switzerland, October 1988. Toronto : Hogrefe & Huber, 1990.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
17

Peter, Burckhardt, dir. Disodium pamidronate (APD) in the treatment of malignancy-related disorders. Toronto : Huber, 1989.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
18

Meyer, James L. I loved a boy : Confessions of a Roman Catholic priest. Royal Oak, Mich : Van Antwerp and Beale Publishers, 2007.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
19

Meyer, James L. I loved a boy : Confessions of a Roman Catholic priest. Royal Oak, Mich : Van Antwerp and Beale Publishers, 2007.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
20

Shorey, Seema. Differences in the degree to which osteoclasts from different parts of the skeleton employ cathepsin K and matrix metalloproteinases for bone resorption. Ottawa : National Library of Canada, 2002.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
21

Tai, Victoria. The effects of leukotriene Bb4s on osteoclast formation and osteoclastic bone resorption and the role of osteoblastic cells in these processes. Ottawa : National Library of Canada = Bibliothèque nationale du Canada, 1999.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
22

Mundy, Gregory R. Bone remodeling and its disorders. London : Martin Dunitz, 1994.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
23

Mundy, Gregory R. Bone remodeling and its disorders. London : Martin Dunitz, 1995.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
24

Bronner, Felix, Janet Rubin et Mary C. Farach-Carson. Bone Resorption. Springer London, Limited, 2010.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
25

Bronner, Felix, Janet Rubin et Mary C. Farach-Carson. Bone Resorption. Springer London, Limited, 2006.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
26

Harvey, Wilson, et Alan Bennett. Prostaglandins in Bone Resorption. CRC Press, 2020. http://dx.doi.org/10.1201/9780429279195.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
27

Harvey, Wilson, et Alan Bennett. Prostaglandins in Bone Resorption. Taylor & Francis Group, 2020.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
28

Harvey, Wilson, et Alan Bennett. Prostaglandins in Bone Resorption. Taylor & Francis Group, 2020.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
29

Harvey, Wilson, et Alan Bennett. Prostaglandins in Bone Resorption. Taylor & Francis Group, 2020.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
30

Harvey, Wilson, et Alan Bennett. Prostaglandins in Bone Resorption. Taylor & Francis Group, 2019.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
31

Harvey, Wilson, et Alan Bennett. Prostaglandins in Bone Resorption. Taylor & Francis Group, 2020.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
32

Bone resorption, metastasis, and diphosphonates. New York : Raven Press, 1985.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
33

Shanbhag, Arun, Harry E. Rubash et Joshua J. Jacobs, dir. Joint Replacement and Bone Resorption. CRC Press, 2005. http://dx.doi.org/10.1201/b14138.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
34

Rubash, Harry E., Arun Shanbhag et Joshua J. Jacobs. Joint Replacement and Bone Resorption. Taylor & Francis Group, 2019.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
35

OGURA, HIDEAKI. Pharmacological Approach to the Study of the Formation and the Resorption Mechanism of Hard Tissues. MEDICO DENTAL MEDIA INTERNATIONAL, 1994.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
36

Osteoblasts : Morphology, Functions and Clinical Implications. Nova Science Pub Inc, 2013.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
37

Anderson, Paul, Borje Edgar Christopher Nordin et Howard Arthur Morris. Physiological Basis of Metabolic Bone Disease. Taylor & Francis Group, 2014.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
38

Anderson, Paul, Borje Edgar Christopher Nordin et Howard Arthur Morris. Physiological Basis of Metabolic Bone Disease. Taylor & Francis Group, 2014.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
39

Anderson, Paul, Howard A. Morris et B. E. Christopher Nordin. Physiological Basis of Metabolic Bone Disease. Taylor & Francis Group, 2017.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
40

Anderson, Paul, Borje Edgar Christopher Nordin et Howard Arthur Morris. Physiological Basis of Metabolic Bone Disease. Taylor & Francis Group, 2014.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
41

Rubash, Harry E., Arun Shanbhag et Joshua J. Jacobs. Joint Replacement and Bone Resorption : Pathology, Biomaterials and Clinical Practice. Taylor & Francis Group, 2005.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
42

(Editor), Arun Shanbhag, Harry E. Rubash (Editor) et Joshua J. Jacobs (Editor), dir. Joint Replacement and Bone Resorption : Pathology, Biomaterials and Clinical Practice. Informa Healthcare, 2005.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
43

Rubash, Harry E., Arun Shanbhag et Joshua J. Jacobs. Joint Replacement and Bone Resorption : Pathology, Biomaterials and Clinical Practice. Taylor & Francis Group, 2005.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
44

Mansfield, Ian David. The synthesis of novel agents which inhibit tumour-stimulated bone resorption. 1999.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
45

The relationship between bone mineral density and selected variables : An epidemiological perspective. 1990.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
46

Javaid, Kassim. Paget’s disease of bone. Sous la direction de Patrick Davey et David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0274.

Texte intégral
Résumé :
Paget’s disease of bone is an uncommon bone disorder with increased bone resorption and disorganized bone formation of woven bone. Its cause is unclear; there is a clear genetic component but additional environmental factors are important, given the reduction in severity and prevalence in the UK. Paget’s disease is usually asymptomatic and detected by an unexplained raised alkaline phosphatase on routine biochemistry. Symptoms include focal bone pain, including headache. Other symptoms include bone deformity and complications such as fracture and nerve conduction. Paget’s disease can sometimes present with immobilization-associated hypercalcaemia or high-output cardiac failure, and rarely can transform to an osteosarcoma. This chapter addresses the clinical features, diagnosis, and management of Paget’s disease of bone.
Styles APA, Harvard, Vancouver, ISO, etc.
47

Effects of prostaglandin Eb2s on chick bone rudiments in vitro : Studies on bone resorption and formation. Ottawa : National Library of Canada, 1990.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
48

Wordsworth, B. P. Skeletal dysplasias. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0150.

Texte intégral
Résumé :
Bone is metabolically active throughout life and metabolic disturbances may have wide-ranging consequences that are not restricted to altering its mechanics. The study of some genetic bone diseases has already provided remarkable insights into the normal regulation of bone metabolism. Skeletal dysplasias are developmental disorders of the chondro-osseous tissues commonly resulting in short stature, which is often disproportionate. The underlying mutations are often in the structural genes encoding components of the matrix but may also involve growth factors or cell signalling. In contrast, the dysostoses tend to affect single bones or groups of bones, reflecting the transient nature of the many different signalling factors to which they are responsive during development. Abnormalities of bone density (high or low) may be due to primary deficiency of bone matrix synthesis (e.g. osteogenesis imperfecta and hypophosphatasia) but may also reflect an imbalance between bone formation and resorption. This may be caused by abnormalities of bone formation (e.g. hyperostosis/sclerosteosis and osteoporosis pseudoglioma syndrome) or bone resorption (e.g. classic osteopetrosis and fibrous dysplasia).
Styles APA, Harvard, Vancouver, ISO, etc.
49

Ralston, Stuart H. Paget’s disease of bone. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0144.

Texte intégral
Résumé :
Paget's disease of bone (PDB) affects up to 1% of people of European origin aged 55 years and above. It is characterized by focal abnormalities of bone remodelling which disrupt normal bone architecture, leading to expansion and reduced mechanical strength of affected bones. This can lead to various complications including deformity, fracture, nerve compression syndromes, and osteoarthritis, although many patients are asymptomatic. Genetic factors play a key role in the pathogenesis of PDB. This seems to be mediated by a combination of rare genetic variants which cause familial forms of the disease and common variants which increase susceptibility to environmental triggers. Environmental factors which have been suggested to predispose to PDB include viral infections, calcium and vitamin D deficiency, and excessive mechanical loading of affected bones. The diagnosis can be made by the characteristic changes seen on radiographs, but isotope bone scans are helpful in defining disease extent. Serum alkaline phosphatase levels can be used as a measure of disease activity. Inhibitors of bone resorption are the mainstay of medical management for PDB and bisphosphonates are regarded as the treatment of choice. Bisphosphonates are highly effective at reducing bone turnover in PDB and have been found to heal osteolytic lesions, and normalize bone histology. Although bisphosphonates can improving bone pain caused by elevated bone turnover, most patients require additional therapy to deal with symptoms associated with disease complications. It is currently unclear whether bisphosphonate therapy is effective at preventing complications of PDB.
Styles APA, Harvard, Vancouver, ISO, etc.
50

Ralston, Stuart H. Paget’s disease of bone. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199642489.003.0144_update_001.

Texte intégral
Résumé :
Paget’s disease of bone (PDB) affects up to 1% of people of European origin aged 55 years and above. It is characterized by focal abnormalities of bone remodelling which disrupt normal bone architecture, leading to expansion and reduced mechanical strength of affected bones. This can lead to various complications including deformity, fracture, nerve compression syndromes, and osteoarthritis, although many patients are asymptomatic. Genetic factors play a key role in the pathogenesis of PDB. This seems to be mediated by a combination of rare genetic variants which cause familial forms of the disease and common variants which increase susceptibility to environmental triggers. Environmental factors which have been suggested to predispose to PDB include viral infections, calcium and vitamin D deficiency, and excessive mechanical loading of affected bones. The diagnosis can be made by the characteristic changes seen on radiographs, but isotope bone scans are helpful in defining disease extent. Serum alkaline phosphatase levels can be used as a measure of disease activity. Inhibitors of bone resorption are the mainstay of medical management for PDB and bisphosphonates are regarded as the treatment of choice. Bisphosphonates are highly effective at reducing bone turnover in PDB and have been found to heal osteolytic lesions, and normalize bone histology. Although bisphosphonates can improving bone pain caused by elevated bone turnover, most patients require additional therapy to deal with symptoms associated with disease complications. It is currently unclear whether bisphosphonate therapy is effective at preventing complications of PDB.
Styles APA, Harvard, Vancouver, ISO, etc.
Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!

Vers la bibliographie